Covered recipient · General Payments record
BILLY T HOUR
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2024
$3,362.28
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.97 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $270.12 | 13 |
| GlaxoSmithKline, LLC. | $131.25 | 4 |
| Acerta Pharma LLC | $56.37 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.37 | 1 |
| Retrophin, Inc. | $25.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.62 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601854 | CMS |
| Amgen Inc. | $22.16 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601856 | CMS |
| Amgen Inc. | $25.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601858 | CMS |
| Amgen Inc. | $18.77 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601860 | CMS |
| Amgen Inc. | $8.88 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601862 | CMS |
| Amgen Inc. | $32.98 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601864 | CMS |
| Amgen Inc. | $21.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601866 | CMS |
| Amgen Inc. | $27.26 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601868 | CMS |
| Amgen Inc. | $12.79 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601870 | CMS |
| Amgen Inc. | $20.54 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601872 | CMS |
| Amgen Inc. | $25.80 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601874 | CMS |
| Amgen Inc. | $13.02 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601876 | CMS |
| Amgen Inc. | $20.18 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111601878 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.94 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105392266 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.42 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104690692 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.01 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105828969 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.01 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086121986 | CMS |
| GlaxoSmithKline, LLC. | $34.96 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116312758 | CMS |
| GlaxoSmithKline, LLC. | $34.85 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307659 | CMS |
| GlaxoSmithKline, LLC. | $31.66 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116444276 | CMS |
| GlaxoSmithKline, LLC. | $29.78 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116591549 | CMS |
| Novartis Pharmaceuticals Corporation | $26.37 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086784261 | CMS |
| Travere Therapeutics, Inc. | $25.85 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149936168 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.